{
  "created_at": "2020-07-23T23:09:15.000Z",
  "updated_at": "2021-01-06T08:25:02.082Z",
  "id": "b7dd8470-73b5-465f-ba2e-f039aec0061d",
  "labels": "current-affairs,2020-07-24",
  "question": "Which Indian vaccine maker is to begin trials of the Covid-19 vaccine candidate developed by Oxford University-AstraZeneca?",
  "option1": "Serum Institute of India",
  "option2": "Biocon",
  "option3": "Panacea Biotech",
  "option4": "Cadila Healthcare",
  "option5": "",
  "answer": "Serum Institute of India",
  "explanation": "Pune-based Serum Institute of India announced that the company will start trials of the Covid-19 vaccine candidate developed by Oxford University-AstraZeneca.\r\nThe trials are to be carried out by the end of August on about 5,000 Indian volunteers after getting the necessary permissions. The company also hoped that the vaccine will be hopefully launched by June next year. To manufacture 300 million doses, the company is to spend USD 200 million."
}